Pharmaceuticals, Biotechnology and Life Sciences
“Growth strategies for big pharma companies are increasingly dependent on expansion into emerging markets,” says a market research analyst at Infiniti Research.
DUBLIN–(BUSINESS WIRE)–The “Latin America Pharmaceutical Excipients Market by Functionality (Fillers, Coating, Disintegrants, Binders, Lubricants, Preservatives, Emulsifying Agents, Lubricants, Glidants, Diluents),…
In a daily briefing, Daily Stock Tracker (DST) gave some insight on certain biotech stocks, noting that the global Pharmaceutical industry is dominated by the American and European markets. According to Forbes’ top companies of 2017, the ten biggest drug companies are all located in these two regions.
The partnerships and deals struck at CPhI Russia have helped establish Russia at the forefront of pharmerging markets and it is expected to reach a value of $31.2 billion by 2019.
U.S. President Donald Trump’s vow to roll back government regulations at least 75 percent is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would make it harder to secure insurance coverage for pricey new medicines.
U.S. President Donald Trump, who has accused drugmakers of “getting away with murder” on prices, will meet executives from the pharmaceutical industry at the White House on Tuesday.
For the last year, Sanofi’s chief executive has made clear his quest for deals to help revive the fortunes of France’s biggest drugmaker.
The market is still waiting. Olivier Brandicourt’s failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors.
Two UK-based biopharma companies, Mereo BioPharma and Diurnal have reshuffled their managerial lineups by swapping managers and welcoming new people.
Author: Anna Michael, The Study Abroad Portal The Study Abroad Portal helps students worldwide to make the right decision with…
Analytical company Eurofins Scientific has broadened its testing facilities in Spain, as it is about to buy a Spanish pharmaceutical company Villapharma Research SL.